MDxHealth SA Cash on Hand 2018-2025 | MDXH
MDxHealth SA cash on hand from 2018 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
MDxHealth SA Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $47 |
| 2023 | $22 |
| 2022 | $16 |
| 2021 | $58 |
| 2020 | $16 |
| 2019 | $22 |
| 2018 | $26 |
| 2017 | $17 |
| 2016 | |
|
MDxHealth SA Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $32 |
| 2025-03-31 | $66 |
| 2024-12-31 | $47 |
| 2024-09-30 | $49 |
| 2024-06-30 | $21 |
| 2024-03-31 | $14 |
| 2023-12-31 | $22 |
| 2023-09-30 | $33 |
| 2023-06-30 | |
| 2023-03-31 | $48 |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | $40 |
| 2022-03-31 | |
| 2021-12-31 | $58 |
| 2021-06-30 | $31 |
| 2020-12-31 | $16 |
| 2020-06-30 | $24 |
| 2019-12-31 | $22 |
| 2019-06-30 | $12 |
| 2018-12-31 | $26 |
| 2017-12-31 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.171B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.560B | 43.44 |
| Tempus AI (TEM) | United States | $11.946B | 0.00 |
| Doximity (DOCS) | United States | $7.787B | 32.06 |
| Hims & Hers Health (HIMS) | United States | $7.330B | 59.63 |
| IRhythm Technologies (IRTC) | United States | $5.008B | 0.00 |
| Hinge Health (HNGE) | United States | $3.710B | 0.00 |
| Privia Health (PRVA) | United States | $2.835B | 177.31 |
| Heartflow (HTFL) | United States | $2.731B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.687B | 44.45 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.306B | 47.15 |
| Azenta (AZTA) | United States | $1.771B | 72.64 |
| Enovis (ENOV) | United States | $1.410B | 7.41 |
| Schrodinger (SDGR) | United States | $1.349B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.111B | 0.00 |
| Phreesia (PHR) | United States | $1.000B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Talkspace (TALK) | United States | $0.659B | 132.67 |
| Standard BioTools (LAB) | United States | $0.627B | 0.00 |
| Claritev (CTEV) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.448B | 0.00 |
| Carlsmed (CARL) | United States | $0.379B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.355B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.268B | 0.00 |
| CapsoVision (CV) | United States | $0.266B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.207B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.178B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.124B | 6.81 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| HeartBeam (BEAT) | United States | $0.083B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.045B | 0.00 |
| 111 (YI) | China | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |